Judy Li,  Ph.D.

Judy Li, Ph.D. Email and Phone Number

Executive Director, Head of Hematology Strategy, Oncology Statistics at AstraZeneca @ AstraZeneca
cambridge, cambridgeshire, united kingdom
Judy Li, Ph.D.'s Location
San Francisco, California, United States, United States
About Judy Li, Ph.D.

• Former FDA master reviewer for a wide spectrum of regulatory applications and approvals • Hands-on experience leading biometric team through multiple successful global fillings and large phase II/III programs • Over 15 years of clinical development experience across multiple therapeutic areas, including hematology, oncology, and immunology, as well as special clinical settings for multiregional clinical trials, rare disease and pediatric trials• Demonstrated authentic leadership skills and coaching style in talent development, building a culture of diversity and managing high performance teams of different expertise• Unwavering dedication to advancing innovative statistical methodologies and quantitative science in the healthcare arena to enhancing patient outcomes

Judy Li, Ph.D.'s Current Company Details
AstraZeneca

Astrazeneca

View
Executive Director, Head of Hematology Strategy, Oncology Statistics at AstraZeneca
cambridge, cambridgeshire, united kingdom
Website:
astrazeneca.com
Employees:
59317
Judy Li, Ph.D. Work Experience Details
  • Astrazeneca
    Executive Director, Late Oncology Statistics, Head Of Hematology Strategy
    Astrazeneca 2023 - Present
  • Bristol Myers Squibb
    Head Of Lymphoma Cluster Biostatistics
    Bristol Myers Squibb 2022 - 2023
  • Bristol Myers Squibb
    Senior Director & Biostatistics Lead At San Diego Site
    Bristol Myers Squibb 2020 - 2022
  • Celgene
    Director Biostatistics
    Celgene 2018 - 2020
  • Regeneron Pharmaceuticals, Inc.
    Associate Director Biostatistics
    Regeneron Pharmaceuticals, Inc. 2017 - 2018
  • Fda
    Master Reviewer/Supervisory Mathematical Statistician
    Fda 2010 - 2017
    Serve as a special expert in statistical regulatory review. Review, evaluate and provide overall quantitative risk and benefit assessment of late phase IND, IDE, BLA and PMA applications, including the review of study design, conduct, statistical methodologies & inferences, and the interpretation of the study results as part of the proposed labeling. Review areas include hematology, cell therapy, neurology, immunology biologic related product, pathogen reduced device, and rare disease.
  • Statistical Consulting Collaboratory, University Of California Riversie
    Statistical Consultant
    Statistical Consulting Collaboratory, University Of California Riversie 2007 - 2010
    Work in the academic consulting environment, lead projects and supervise a team of statisticians in providing statistical services including innovative design and advanced statistical analyses.

Judy Li, Ph.D. Education Details

Frequently Asked Questions about Judy Li, Ph.D.

What company does Judy Li, Ph.D. work for?

Judy Li, Ph.D. works for Astrazeneca

What is Judy Li, Ph.D.'s role at the current company?

Judy Li, Ph.D.'s current role is Executive Director, Head of Hematology Strategy, Oncology Statistics at AstraZeneca.

What schools did Judy Li, Ph.D. attend?

Judy Li, Ph.D. attended The Wharton School, University Of California, Berkeley, Haas School Of Business, University Of California, Riverside.

Who are Judy Li, Ph.D.'s colleagues?

Judy Li, Ph.D.'s colleagues are Rehna Jose, San Chan, Hanna Hagelin, Sophie Lebuhotel, Chelsea Bailey, Sipho Sikhakhane, Wei/abby Zhou.

Not the Judy Li, Ph.D. you were looking for?

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.